Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam (Keppra®) (SOLUCION Study)

NCT00319605 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00319605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00319605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam (Keppra®) (SOLUCION Study)
Lead sponsor
UCB Pharma
Phase
Observational
Overall status
Completed
Start date
April 30, 2006
Completion date
July 31, 2006
Enrollment
600 (estimated)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy